{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:06:40Z","timestamp":1779080800229,"version":"3.51.4"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011738","name":"Lee Kong Chian School of Medicine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011738","id-type":"DOI","asserted-by":"crossref"}]},{"name":"School of Chemistry, Chemical Engineering, and Biotechnology"},{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","award":["#025402-00001"],"award-info":[{"award-number":["#025402-00001"]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microbiome"],"DOI":"10.1186\/s40168-026-02405-w","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T01:56:24Z","timestamp":1775699784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cross-body site microbial interactions influence the human plasma metabolome"],"prefix":"10.1186","volume":"14","author":[{"given":"Jingxiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunny","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"2405_CR1","doi-asserted-by":"crossref","unstructured":"The Integrative HMP (iHMP) Research Network Consortium, Proctor LM, Creasy HH, Fettweis JM, Lloyd-Price J, Mahurkar A, Zhou W, Buck GA, Snyder MP, Strauss JF III, Weinstock GM, White O, Huttenhower C.\u00a0The Integrative Human Microbiome Project. Nature. 2019;569:641\u20138.","DOI":"10.1038\/s41586-019-1238-8"},{"key":"2405_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou K, et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022;7:135.","journal-title":"Signal Transduct Target Ther"},{"key":"2405_CR3","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1038\/s41467-019-12476-z","volume":"10","author":"A Visconti","year":"2019","unstructured":"Visconti A, et al. Interplay between the human gut microbiome and host metabolism. Nat Commun. 2019;10:4505.","journal-title":"Nat Commun"},{"key":"2405_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0303-2","volume":"8","author":"CL Boulang\u00e9","year":"2016","unstructured":"Boulang\u00e9 CL, Neves AL, Chilloux J, Nicholson JK, Dumas M-E. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016;8:42.","journal-title":"Genome Med"},{"key":"2405_CR5","doi-asserted-by":"publisher","first-page":"4986","DOI":"10.1038\/s41467-023-40552-y","volume":"14","author":"L Zhai","year":"2023","unstructured":"Zhai L, et al. Gut microbiota-derived tryptamine and phenethylamine impair insulin sensitivity in metabolic syndrome and irritable bowel syndrome. Nat Commun. 2023;14:4986.","journal-title":"Nat Commun"},{"key":"2405_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41586-023-06466-x","volume":"621","author":"T Takeuchi","year":"2023","unstructured":"Takeuchi T, et al. Gut microbial carbohydrate metabolism contributes to insulin resistance. Nature. 2023;621:389\u201395.","journal-title":"Nature"},{"key":"2405_CR7","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1038\/s41467-022-33050-0","volume":"13","author":"KF Dekkers","year":"2022","unstructured":"Dekkers KF, et al. An online atlas of human plasma metabolite signatures of gut microbiome composition. Nat Commun. 2022;13:5370.","journal-title":"Nat Commun"},{"key":"2405_CR8","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1038\/s41591-022-02014-8","volume":"28","author":"L Chen","year":"2022","unstructured":"Chen L, et al. Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome. Nat Med. 2022;28:2333\u201343.","journal-title":"Nat Med"},{"key":"2405_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10071405","volume":"10","author":"S Thangaleela","year":"2022","unstructured":"Thangaleela S, Sivamaruthi BS, Kesika P, Bharathi M, Chaiyasut C. Nasal microbiota, olfactory health, neurological disorders and aging-a review. Microorganisms. 2022;10:1405.","journal-title":"Microorganisms"},{"key":"2405_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113071","volume":"23","author":"H-J Lee","year":"2022","unstructured":"Lee H-J, Kim M. Skin barrier function and the microbiome. Int J Mol Sci. 2022;23:13071.","journal-title":"Int J Mol Sci"},{"key":"2405_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41579-023-00963-6","volume":"22","author":"JL Baker","year":"2024","unstructured":"Baker JL, Mark Welch JL, Kauffman KM, McLean JS, He X. The oral microbiome: diversity, biogeography and human health. Nat Rev Microbiol. 2024;22:89\u2013104.","journal-title":"Nat Rev Microbiol"},{"key":"2405_CR12","doi-asserted-by":"publisher","first-page":"1010368","DOI":"10.3389\/fimmu.2022.1010368","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, et al. The oral microbiota and cardiometabolic health: A comprehensive review and emerging insights. Front Immunol. 2022;13:1010368.","journal-title":"Front Immunol"},{"key":"2405_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00150-24","volume":"38","author":"X Liu","year":"2025","unstructured":"Liu X, et al. Oral microbiota and respiratory diseases: advances and perspectives. Clin Microbiol Rev. 2025;38:e0015024.","journal-title":"Clin Microbiol Rev"},{"key":"2405_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nrmicro2537","volume":"9","author":"EA Grice","year":"2011","unstructured":"Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9:244\u201353.","journal-title":"Nat Rev Microbiol"},{"key":"2405_CR15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41385-019-0160-6","volume":"12","author":"AT Dang","year":"2019","unstructured":"Dang AT, Marsland BJ. Microbes, metabolites, and the gut-lung axis. Mucosal Immunol. 2019;12:843\u201350.","journal-title":"Mucosal Immunol"},{"key":"2405_CR16","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41579-024-01075-5","volume":"22","author":"BJ Kunath","year":"2024","unstructured":"Kunath BJ, De Rudder C, Laczny CC, Letellier E, Wilmes P. The oral-gut microbiome axis in health and disease. Nat Rev Microbiol. 2024;22:791\u2013805.","journal-title":"Nat Rev Microbiol"},{"key":"2405_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-025-00646-5","volume":"11","author":"Q Xu","year":"2025","unstructured":"Xu Q, et al. The oral-gut microbiota axis: a link in cardiometabolic diseases. NPJ Biofilms Microbiomes. 2025;11:11.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"2405_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuab039","volume":"46","author":"A Barbour","year":"2022","unstructured":"Barbour A, Elebyary O, Fine N, Oveisi M, Glogauer M. Metabolites of the oral microbiome: important mediators of multikingdom interactions. FEMS Microbiol Rev. 2022;46:fuab039.","journal-title":"FEMS Microbiol Rev"},{"key":"2405_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-03122-4","volume":"14","author":"S Malan-M\u00fcller","year":"2024","unstructured":"Malan-M\u00fcller S, et al. Probing the oral-brain connection: oral microbiome patterns in a large community cohort with anxiety, depression, and trauma symptoms, and periodontal outcomes. Transl Psychiatry. 2024;14:419.","journal-title":"Transl Psychiatry"},{"key":"2405_CR20","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/s41564-024-01680-3","volume":"9","author":"C Liao","year":"2024","unstructured":"Liao C, et al. Oral bacteria relative abundance in faeces increases due to gut microbiota depletion and is linked with patient outcomes. Nat Microbiol. 2024;9:1555\u201365.","journal-title":"Nat Microbiol"},{"key":"2405_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-022-00183-3","volume":"14","author":"J Bao","year":"2022","unstructured":"Bao J, et al. Periodontitis may induce gut microbiota dysbiosis via salivary microbiota. Int J Oral Sci. 2022;14:32.","journal-title":"Int J Oral Sci"},{"key":"2405_CR22","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s43587-024-00692-2","volume":"4","author":"X Shen","year":"2024","unstructured":"Shen X, et al. Nonlinear dynamics of multi-omics profiles during human aging. Nat Aging. 2024;4:1619\u201334.","journal-title":"Nat Aging"},{"key":"2405_CR23","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-019-1236-x","volume":"569","author":"W Zhou","year":"2019","unstructured":"Zhou W, et al. Longitudinal multi-omics of host-microbe dynamics in prediabetes. Nature. 2019;569:663\u201371.","journal-title":"Nature"},{"key":"2405_CR24","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.chom.2024.02.012","volume":"32","author":"X Zhou","year":"2024","unstructured":"Zhou X, et al. Longitudinal profiling of the microbiome at four body sites reveals core stability and individualized dynamics during health and disease. Cell Host Microbe. 2024;32:506-526.e9.","journal-title":"Cell Host Microbe"},{"key":"2405_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41042-x","volume":"14","author":"S Shoer","year":"2023","unstructured":"Shoer S, et al. Impact of dietary interventions on pre-diabetic oral and gut microbiome, metabolites and cytokines. Nat Commun. 2023;14:5384.","journal-title":"Nat Commun"},{"key":"2405_CR26","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/s41467-025-56084-6","volume":"16","author":"X Wu","year":"2025","unstructured":"Wu X, et al. A legume-enriched diet improves metabolic health in prediabetes mediated through gut microbiome: a randomized controlled trial. Nat Commun. 2025;16:942.","journal-title":"Nat Commun"},{"key":"2405_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","volume":"19","author":"KA Krautkramer","year":"2021","unstructured":"Krautkramer KA, Fan J, B\u00e4ckhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2021;19:77\u201394.","journal-title":"Nat Rev Microbiol"},{"key":"2405_CR28","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","volume":"70","author":"A Agus","year":"2021","unstructured":"Agus A, Cl\u00e9ment K, Sokol H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut. 2021;70:1174\u201382.","journal-title":"Gut"},{"key":"2405_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nm.4272","volume":"23","author":"DM Chu","year":"2017","unstructured":"Chu DM, et al. Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat Med. 2017;23:314\u201326.","journal-title":"Nat Med"},{"key":"2405_CR30","doi-asserted-by":"publisher","first-page":"19738","DOI":"10.1038\/s41598-022-21453-4","volume":"12","author":"VO Baede","year":"2022","unstructured":"Baede VO, et al. Nasal microbiome disruption and recovery after mupirocin treatment in Staphylococcus aureus carriers and noncarriers. Sci Rep. 2022;12:19738.","journal-title":"Sci Rep"},{"key":"2405_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1298632","volume":"14","author":"JY Seo","year":"2023","unstructured":"Seo JY, et al. Longitudinal study of the interplay between the skin barrier and facial microbiome over 1\u2009year. Front Microbiol. 2023;14:1298632.","journal-title":"Front Microbiol"},{"key":"2405_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41522-025-00661-6","volume":"11","author":"Q Qu","year":"2025","unstructured":"Qu Q, et al. Population-level gut microbiome and its associations with environmental factors and metabolic disorders in Southwest China. NPJ Biofilms Microbiomes. 2025;11:24.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"2405_CR33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41522-024-00567-9","volume":"10","author":"W Sun","year":"2024","unstructured":"Sun W, et al. A population-scale analysis of 36 gut microbiome studies reveals universal species signatures for common diseases. NPJ Biofilms Microbiomes. 2024;10:96.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"2405_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1278582","volume":"13","author":"MI Hammad","year":"2023","unstructured":"Hammad MI, Conrads G, Abdelbary MMH. Isolation, identification, and significance of salivary Veillonella spp., Prevotella spp., and Prevotella salivae in patients with inflammatory bowel disease. Front Cell Infect Microbiol. 2023;13:1278582.","journal-title":"Front Cell Infect Microbiol"},{"key":"2405_CR35","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12866-020-01801-y","volume":"20","author":"E Caselli","year":"2020","unstructured":"Caselli E, et al. Defining the oral microbiome by whole-genome sequencing and resistome analysis: the complexity of the healthy picture. BMC Microbiol. 2020;20:120.","journal-title":"BMC Microbiol"},{"key":"2405_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.798763","volume":"12","author":"E K\u00f6n\u00f6nen","year":"2021","unstructured":"K\u00f6n\u00f6nen E, Gursoy UK. Oral Prevotella species and their connection to events of clinical relevance in gastrointestinal and respiratory tracts. Front Microbiol. 2021;12:798763.","journal-title":"Front Microbiol"},{"key":"2405_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","author":"Human Microbiome Project Consortium","year":"2012","unstructured":"Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207\u201314.","journal-title":"Nature"},{"key":"2405_CR38","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41587-019-0233-9","volume":"37","author":"T Wilmanski","year":"2019","unstructured":"Wilmanski T, et al. Blood metabolome predicts gut microbiome \u03b1-diversity in humans. Nat Biotechnol. 2019;37:1217\u201328.","journal-title":"Nat Biotechnol"},{"key":"2405_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.chom.2022.11.015","volume":"31","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, et al. Two distinct gut microbial pathways contribute to meta-organismal production of phenylacetylglutamine with links to cardiovascular disease. Cell Host Microbe. 2023;31:18-32.e9.","journal-title":"Cell Host Microbe"},{"issue":"Suppl 1","key":"2405_CR40","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1073\/pnas.1000098107","volume":"108","author":"J van Duynhoven","year":"2011","unstructured":"van Duynhoven J, et al. Metabolic fate of polyphenols in the human superorganism. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4531\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2405_CR41","doi-asserted-by":"crossref","unstructured":"Pascal Andreu V, et al. gutSMASH predicts specialized primary metabolic pathways from the human gut microbiota. Nat Biotechnol. 2023;41:1416\u20131423.","DOI":"10.1038\/s41587-023-01675-1"},{"key":"2405_CR42","doi-asserted-by":"publisher","first-page":"2446391","DOI":"10.1080\/19490976.2024.2446391","volume":"17","author":"P Wang","year":"2025","unstructured":"Wang P, et al. Gut microbiota-derived 4-hydroxyphenylacetic acid from resveratrol supplementation prevents obesity through SIRT1 signaling activation. Gut Microbes. 2025;17:2446391.","journal-title":"Gut Microbes"},{"key":"2405_CR43","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.tree.2023.04.015","volume":"38","author":"LA Malard","year":"2023","unstructured":"Malard LA, Guisan A. Into the microbial niche. Trends Ecol Evol. 2023;38:936\u201345.","journal-title":"Trends Ecol Evol"},{"key":"2405_CR44","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41586-020-2896-2","volume":"588","author":"N Bar","year":"2020","unstructured":"Bar N, et al. A reference map of potential determinants for the human serum metabolome. Nature. 2020;588:135\u201340.","journal-title":"Nature"},{"key":"2405_CR45","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature24661","volume":"551","author":"D Dodd","year":"2017","unstructured":"Dodd D, et al. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature. 2017;551:648\u201352.","journal-title":"Nature"},{"key":"2405_CR46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature18847","volume":"535","author":"CA Thaiss","year":"2016","unstructured":"Thaiss CA, Zmora N, Levy M, Elinav E. The microbiome and innate immunity. Nature. 2016;535:65\u201374.","journal-title":"Nature"},{"key":"2405_CR47","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.cell.2016.10.020","volume":"167","author":"M Schirmer","year":"2016","unstructured":"Schirmer M, et al. Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity. Cell. 2016;167:1125-1136.e8.","journal-title":"Cell"},{"key":"2405_CR48","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.cell.2024.03.014","volume":"187","author":"C Li","year":"2024","unstructured":"Li C, et al. Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteria. Cell. 2024;187:1834-1852.e19.","journal-title":"Cell"},{"key":"2405_CR49","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/s42255-022-00670-1","volume":"4","author":"C Diener","year":"2022","unstructured":"Diener C, et al. Genome-microbiome interplay provides insight into the determinants of the human blood metabolome. Nat Metab. 2022;4:1560\u201372.","journal-title":"Nat Metab"},{"key":"2405_CR50","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nm.4358","volume":"23","author":"R Liu","year":"2017","unstructured":"Liu R, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med. 2017;23:859\u201368.","journal-title":"Nat Med"},{"key":"2405_CR51","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7155\/2\/1\/017017","volume":"2","author":"D Codipilly","year":"2008","unstructured":"Codipilly D, Kleinberg I. Generation of indole\/skatole during malodor formation in the salivary sediment model system and initial examination of the oral bacteria involved. J Breath Res. 2008;2:017017.","journal-title":"J Breath Res"},{"key":"2405_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05470-4","volume":"9","author":"HM Roager","year":"2018","unstructured":"Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun. 2018;9:3294.","journal-title":"Nat Commun"},{"key":"2405_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-01750-y","volume":"12","author":"G Wang","year":"2024","unstructured":"Wang G, et al. Microbiota-derived indoles alleviate intestinal inflammation and modulate microbiome by microbial cross-feeding. Microbiome. 2024;12:59.","journal-title":"Microbiome"},{"key":"2405_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03642-6","author":"H Wu","year":"2025","unstructured":"Wu H, et al. Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med. 2025. https:\/\/doi.org\/10.1038\/s41591-025-03642-6.","journal-title":"Nat Med"},{"key":"2405_CR55","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.tem.2020.02.012","volume":"31","author":"Y Liu","year":"2020","unstructured":"Liu Y, Hou Y, Wang G, Zheng X, Hao H. Gut microbial metabolites of aromatic amino acids as signals in host-microbe interplay. Trends Endocrinol Metab TEM. 2020;31:818\u201334.","journal-title":"Trends Endocrinol Metab TEM"},{"key":"2405_CR56","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/s42255-025-01246-5","volume":"7","author":"Z Jiang","year":"2025","unstructured":"Jiang Z, et al. Human gut microbial aromatic amino acid and related metabolites prevent obesity through intestinal immune control. Nat Metab. 2025;7:808\u201322.","journal-title":"Nat Metab"},{"key":"2405_CR57","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41522-025-00669-y","volume":"11","author":"J Ding","year":"2025","unstructured":"Ding J, et al. Regulation of tryptophan-indole metabolic pathway in Porphyromonas gingivalis virulence and microbiota dysbiosis in periodontitis. NPJ Biofilms Microbiomes. 2025;11:37.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"2405_CR58","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/advances\/nmz127","volume":"11","author":"K Gao","year":"2020","unstructured":"Gao K, Mu C-L, Farzi A, Zhu W-Y. Tryptophan metabolism: a link between the gut microbiota and brain. Adv Nutr Bethesda Md. 2020;11:709\u201323.","journal-title":"Adv Nutr Bethesda Md"},{"key":"2405_CR59","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.molmed.2023.08.006","volume":"29","author":"J Pacheco-Yanes","year":"2023","unstructured":"Pacheco-Yanes J, Reynolds E, Li J, Mari\u00f1o E. Microbiome-targeted interventions for the control of oral-gut dysbiosis and chronic systemic inflammation. Trends Mol Med. 2023;29:912\u201325.","journal-title":"Trends Mol Med"},{"key":"2405_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1612223","volume":"15","author":"Z Yang","year":"2025","unstructured":"Yang Z, Du C, Chang Z, Yang Y, Hu L. Role of oral and gut microbiomes in enterosalivary nitrate metabolism and their effects on systemic disease. Front Cell Infect Microbiol. 2025;15:1612223.","journal-title":"Front Cell Infect Microbiol"},{"key":"2405_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102749","volume":"11","author":"GE Leonov","year":"2023","unstructured":"Leonov GE, Varaeva YR, Livantsova EN, Starodubova AV. The complicated relationship of short-chain fatty acids and oral microbiome: a narrative review. Biomedicines. 2023;11:2749.","journal-title":"Biomedicines"},{"key":"2405_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104241","volume":"25","author":"J Brown","year":"2022","unstructured":"Brown J, et al. Microbiota-mediated skewing of tryptophan catabolism modulates CD4+ T\u00a0cells in lupus-prone mice. iScience. 2022;25:104241.","journal-title":"iScience"},{"key":"2405_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01365","volume":"13","author":"H Kaur","year":"2019","unstructured":"Kaur H, Bose C, Mande SS. Tryptophan metabolism by gut microbiome and gut-brain-axis: an in silico analysis. Front Neurosci. 2019;13:1365.","journal-title":"Front Neurosci"},{"key":"2405_CR64","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/sj.bdj.2016.865","volume":"221","author":"M Kilian","year":"2016","unstructured":"Kilian M, et al. The oral microbiome - an update for oral healthcare professionals. Br Dent J. 2016;221:657\u201366.","journal-title":"Br Dent J"},{"key":"2405_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1119201","volume":"14","author":"X-J Guo","year":"2023","unstructured":"Guo X-J, et al. Distribution characteristics of oral microbiota and its relationship with intestinal microbiota in patients with type 2 diabetes mellitus. Front Endocrinol. 2023;14:1119201.","journal-title":"Front Endocrinol"},{"key":"2405_CR66","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12933-024-02217-y","volume":"23","author":"Y Li","year":"2024","unstructured":"Li Y, et al. Oral-gut microbial transmission promotes diabetic coronary heart disease. Cardiovasc Diabetol. 2024;23:123.","journal-title":"Cardiovasc Diabetol"},{"key":"2405_CR67","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/biomedicines10010178","volume":"10","author":"F Barutta","year":"2022","unstructured":"Barutta F, Bellini S, Durazzo M, Gruden G. Novel insight into the mechanisms of the bidirectional relationship between diabetes and periodontitis. Biomedicines. 2022;10:178.","journal-title":"Biomedicines"},{"key":"2405_CR68","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1038\/s41591-024-03067-7","volume":"30","author":"Z Mei","year":"2024","unstructured":"Mei Z, et al. Strain-specific gut microbial signatures in type 2 diabetes identified in a cross-cohort analysis of 8,117 metagenomes. Nat Med. 2024;30:2265\u201376.","journal-title":"Nat Med"},{"key":"2405_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/nu13072229","volume":"13","author":"NF Zakaria","year":"2021","unstructured":"Zakaria NF, Hamid M, Khayat ME. Amino acid-induced impairment of insulin signaling and involvement of G-protein coupling receptor. Nutrients. 2021;13:2229.","journal-title":"Nutrients"},{"key":"2405_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.156389","volume":"499","author":"J Wang","year":"2024","unstructured":"Wang J, et al. Histidine-derived carbon dots for redox modulation and gut microbiota regulation in inflammatory bowel disease therapy. Chem Eng J. 2024;499:156389.","journal-title":"Chem Eng J"},{"key":"2405_CR71","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/ijms20020376","volume":"20","author":"N Hirasawa","year":"2019","unstructured":"Hirasawa N. Expression of histidine decarboxylase and its roles in inflammation. Int J Mol Sci. 2019;20:376.","journal-title":"Int J Mol Sci"},{"key":"2405_CR72","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41588-021-00968-y","volume":"54","author":"X Liu","year":"2022","unstructured":"Liu X, et al. Mendelian randomization analyses support causal relationships between blood metabolites and the gut microbiome. Nat Genet. 2022;54:52\u201361.","journal-title":"Nat Genet"},{"key":"2405_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2023.109690","volume":"239","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, et al. The role of the indoles in microbiota-gut-brain axis and potential therapeutic targets: a focus on human neurological and neuropsychiatric diseases. Neuropharmacology. 2023;239:109690.","journal-title":"Neuropharmacology"},{"key":"2405_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101887","volume":"42","author":"B Korac","year":"2021","unstructured":"Korac B, Kalezic A, Pekovic-Vaughan V, Korac A, Jankovic A. Redox changes in obesity, metabolic syndrome, and diabetes. Redox Biol. 2021;42:101887.","journal-title":"Redox Biol"},{"key":"2405_CR75","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2337\/dc09-1378","volume":"33","author":"WJ Teeuw","year":"2010","unstructured":"Teeuw WJ, Gerdes VEA, Loos BG. Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis. Diabetes Care. 2010;33:421\u20137.","journal-title":"Diabetes Care"},{"key":"2405_CR76","doi-asserted-by":"publisher","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","volume":"50","author":"DS Wishart","year":"2022","unstructured":"Wishart DS, et al. HMDB 5.0: the human metabolome database for 2022. Nucleic Acids Res. 2022;50:D622\u201331.","journal-title":"Nucleic Acids Res"},{"key":"2405_CR77","doi-asserted-by":"publisher","unstructured":"Shen X, Snyder MP. microbiomedataset: A tidyverse-style framework for organizing and processing microbiome data. Preprint at https:\/\/doi.org\/10.1101\/2023.09.17.558096. 2023.","DOI":"10.1101\/2023.09.17.558096"},{"key":"2405_CR78","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1038\/s41467-022-32155-w","volume":"13","author":"X Shen","year":"2022","unstructured":"Shen X, et al. TidyMass an object-oriented reproducible analysis framework for LC-MS data. Nat Commun. 2022;13:4365.","journal-title":"Nat Commun"},{"key":"2405_CR79","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1093\/bioinformatics\/btac546","volume":"38","author":"X Shen","year":"2022","unstructured":"Shen X, Wang C, Snyder MP. MassDatabase: utilities for the operation of the public compound and pathway database. Bioinforma Oxf Engl. 2022;38:4650\u20131.","journal-title":"Bioinforma Oxf Engl"},{"key":"2405_CR80","doi-asserted-by":"crossref","unstructured":"Wang X, Liu Y, et al. TidyMass2: advancing LC-MS untargeted metabolomics through metabolite origin inference and metabolic feature-based functional module analysis. Nat Commun. 2026;17(1):1755.","DOI":"10.1038\/s41467-026-68464-7"}],"container-title":["Microbiome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40168-026-02405-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-026-02405-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-026-02405-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T04:20:05Z","timestamp":1779078005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40168-026-02405-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2405"],"URL":"https:\/\/doi.org\/10.1186\/s40168-026-02405-w","relation":{},"ISSN":["2049-2618"],"issn-type":[{"value":"2049-2618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M.P.S. is a cofounder, scientific advisor, and shareholder of Filtricine, Iollo, January AI, Marble Therapeutics, Next Thought AI, Personalis, Protos Biologics, Qbio, RTHM, and SensOmics. M.P.S. is a scientific advisor and equity holder of Abbratech, Applied Cognition, Enovone, M3 Helium, and Onza. M.P.S. is a scientific advisor and stock option holder of Jupiter Therapeutics, Mitrix, Neuvivo, Sigil Biosciences, WndrHLTH, and Yuvan Research. M.P.S. is a cofounder and stock option holder of Crosshair Therapeutics. M.P.S. is an investor in and scientific advisor of R42 and Swaza. M.P.S. is an investor in Repair Biotechnologies. M.P.S. is a cofounder, shareholder, and director of Exposomics, Fodsel, and InVu Health. M.P.S. is a cofounder and equity holder of Mirvie, NiMo Therapeutics, and Orange Street Ventures. The other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}